We estimate that the President and CEO of HAEMONETICS CORP ($HAE), Christopher A. Simon, received a compensation of $12,044,701 in 2026. This is an increase of 10.98% from an estimated $10,722,488 in 2025.
These estimates are based on a new DEF14A filing, filed with the SEC on June 09, 2026. Note that parsing errors may occur.
You can track $HAE on Quiver Quantitative's $HAE stock dashboard.
$HAE Stock Government Contracts
We have seen $359,568 of award payments to $HAE over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- PORTABLE BLOOD ANALYZERS: $131,896
- HAEMONETICS CORPORATION PROVIDES THE ARTERIAL AND VENOUS CLOSURE SHEATHS REQUIRED FOR CARDIAC ELECTROPHYSIO...: $87,900
- EXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF FEBRUARY 2026: $49,691
- EXPRESS REPORT: NX ORDERS PLACED DURING THE MONTH OF APRIL, 2026: $22,600
- (R) HAEMONETICS CORPORATION:1177264 [25-002935] AUTOMATED CELL PROCESSORS ACP 215 SERIAL NUMBER 19C027SPG ...: $12,166
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard. You can access data on government contracts through the Quiver Quantitative API government contracts endpoint.
$HAE Stock Hedge Fund Activity
We have seen 162 institutional investors add shares of $HAE Stock stock to their portfolio, and 204 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- HOLOCENE ADVISORS, LP removed 1,259,749 shares (-99.6%) from their portfolio in Q1 2026, for an estimated $70,999,453
- CITADEL ADVISORS LLC removed 1,030,279 shares (-80.0%) from their portfolio in Q1 2026, for an estimated $58,066,524
- POINT72 ASSET MANAGEMENT, L.P. removed 796,511 shares (-93.3%) from their portfolio in Q1 2026, for an estimated $44,891,359
- INVENOMIC CAPITAL MANAGEMENT LP added 664,729 shares (+inf%) to their portfolio in Q1 2026, for an estimated $37,464,126
- FISHER ASSET MANAGEMENT, LLC removed 662,504 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $53,099,695
- ROYCE & ASSOCIATES LP removed 629,767 shares (-89.8%) from their portfolio in Q4 2025, for an estimated $50,475,825
- SCHRODER INVESTMENT MANAGEMENT GROUP removed 538,036 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $43,123,585
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$HAE Stock Analyst Ratings
Wall Street analysts have issued reports on $HAE in the last several months. We have seen 2 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- BTIG issued a "Buy" rating on 02/06/2026
- Mizuho issued a "Outperform" rating on 12/17/2025
To track analyst ratings and price targets for $HAE Stock, check out Quiver Quantitative's $HAE forecast page.
$HAE Stock Price Targets
Multiple analysts have issued price targets for $HAE recently. We have seen 8 analysts offer price targets for $HAE in the last 6 months, with a median target of $77.0.
Here are some recent targets:
- Joanne Wuensch from Citigroup set a target price of $70.0 on 05/28/2026
- Craig Bijou from B of A Securities set a target price of $80.0 on 05/22/2026
- Michael Petusky from Barrington Research set a target price of $89.0 on 05/12/2026
- Allen Gong from JP Morgan set a target price of $62.0 on 05/08/2026
- Anthony Petrone from Mizuho set a target price of $70.0 on 04/13/2026
- Marie Thibault from BTIG set a target price of $88.0 on 02/06/2026
- David Rescott from Baird set a target price of $99.0 on 12/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
